Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rangering i aksjer #28166
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Aksjekurs
$0.5495
Sist synkronisert: 2025-05-15
Markedsverdi
$28.14M
Endring (1 dag)
4.70%
Endring (1 år)
0.00%
Land
US
Handel Enzo Biochem, Inc. (ENZ)

Kategori

Antall utestående aksjer for Enzo Biochem, Inc. (ENZ)
Antall utestående aksjer per April 2025: 52.40M
Ifølge Enzo Biochem, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 52.40M. Ved slutten av July 2023 hadde selskapet 49.16M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Enzo Biochem, Inc. (ENZ) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 52.40M 2.95%
2024 50.90M 3.54%
2023 49.16M 1.16%
2022 48.59M 0.84%
2021 48.19M 1.04%
2020 47.70M 0.73%
2019 47.35M 0.93%
2018 46.91M 1.22%
2017 46.35M 0.43%
2016 46.15M 1.76%
2015 45.36M 6.56%
2014 42.56M 7.46%
2013 39.61M 2.09%
2012 38.80M 1.15%
2011 38.36M 0.94%
2010 38.00M 1.31%
2009 37.51M 1.70%
2008 36.88M 5.33%
2007 35.02M 8.70%
2006 32.22M 0.37%
2005 32.10M 1.25%
2004 31.70M -3.85%
2003 32.97M 5.13%
2002 31.36M 0.34%
2001 31.25M 1.51%
2000 30.79M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
371.00M 607.97%
US
705.30M 1,245.92%
US
- -
CN
143.28M 173.42%
US
80.10M 52.85%
US